UT Governments to create awareness and provide health care facilities. Government of India is implementing National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke( NPCDCS) for interventions up to District level under the National Health Mission.
First of its kind Salt Summit held in India
Realizing that salt reduction in India requires a multistakeholder effort that can take into account the growing incidence of hypertension and cardiac diseases largely resulting from intake of sodium beyond the WHO recommended guidelines of 5 mg per day, the George Institute for Global Health in association with Arogya World organized the Salt Summit in the Capital here today.
Inaugurating the Salt Summit, the Health Secretary, Mr C K Mishra, said that the NCD’ s are now recognized by the Government of India as a major health issue and figures as part of the National Health Mission.“ The Ministry will be starting a universal screening program from April onwards covering five NCDs namely diabetes, hypertension, oral, cervical and breast cancers,’’ he informed adding that mortality is more because detection is very low,” he informed.
India is one of the first countries to have developed an action plan for meeting the NCDs 10 targets. One of the targets is 30 percent relative reduction in mean population intake of salt / sodium. This will also directly help in achieving the other target which is 25 % relative reduction in raised blood pressure, or contain the prevalence of raised blood pressure.
Several studies carried out in the developing countries, including India, have been reporting an increase in the prevalence of diet
related chronic noncommunicable diseases( NCDs) like overweight and obesity, diabetes mellitus, hypertension, other cardiovascular diseases( CVDs), cancers etc., especially among urban population.
ISCR launches causality assessment portal for compensation
“ Clinical research professionals need to take a more proactive role in conducting Research for India. A more conducive regulatory framework for the conduct of clinical research will enable this and encourage local innovation, ensuring that Make in India is a reality for drug development and clinical research in India. Such an approach will help make our theme Patients First and Research for India a reality,” said Suneela Thatte, President, Indian Society for Clinical Research( ISCR), at its 10th Annual Clinical Research Conference that was inaugurated in Mumbai.
Launched on the occasion was a Causality
BIOVOICENEWS. COM 69